AQP5 and breast cancer: BrdU cell proliferation assay demonstrated that BrdU incorporation was significantly decreased (69±2% of mock control, P<0.05, Fig. 3C) in MCF7 cells with AQP5 knockdown, indicating that AQP5 knockdown in human breast cancer cells was associated with decreased cell proliferation.